RemeGen Co. Ltd. Class A - Current Ratio

The Current Ratio as of September 2026 (TTM) for RemeGen Co. Ltd. Class A (688331.SS) is 4.86

According to RemeGen Co. Ltd. Class A’s latest financial reports and current stock price. The company's current Current Ratio is 4.86. This represents a change of 120.24% compared to the average of 2.21 of the last 4 quarters.

RemeGen Co. Ltd. Class A (688331.SS) Historical Current Ratio (quarterly & annually)

How has 688331.SS Current Ratio performed in the past?

The mean historical Current Ratio of RemeGen Co. Ltd. Class A over the last ten years is 2.36. The current 4.86 Current Ratio has changed 20.49% with respect to the historical average. Over the past ten years (40 quarters), 688331.SS's Current Ratio was at its highest in in the March 2022 quarter at 7.48. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

RemeGen Co. Ltd. Class A (688331.SS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of RemeGen Co. Ltd. Class A Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

RemeGen Co. Ltd. Class A (688331.SS) Average Current Ratio

How has 688331.SS Current Ratio performed in the past?

The current Current Ratio of RemeGen Co. Ltd. Class A (688331.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

RemeGen Co. Ltd. Class A (688331.SS) Current Ratio vs. Peers

How is 688331.SS’s Current Ratio compared to its peers?

RemeGen Co. Ltd. Class A’s Current Ratio is greater than Pharmaron Beijing Co., Ltd. (1.02), less than Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (25.60), less than Shanghai Allist Pharmaceuticals Co., Ltd. (5.37), greater than Chongqing Zhifei Biological Products Co., Ltd. (2.98), greater than Shanghai Junshi Biosciences Co., Ltd. (1.80), greater than Shanghai RAAS Blood Products Co., Ltd. (4.49), greater than Haisco Pharmaceutical Group Co., Ltd. (1.53), greater than Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (0.75), greater than Sichuan Kelun Pharmaceutical Co., Ltd. Class A (2.09), less than Shenzhen New Industries Biomedical Engineering Co., Ltd. (9.13),

Build a custom stock screener for RemeGen Co. Ltd. Class A (688331.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RemeGen Co. Ltd. Class A using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

RemeGen Co. Ltd. Class A (688331.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like RemeGen Co. Ltd. Class A or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.